Pharmaceutical Executive-03-01-2015

Congress, Obama offer strategies to reduce regulatory roadblocks to new breakthroughs.

Pharma jumps on board personal genomics train-at least for test drive-but will journey ultimately help transform treatment or stall out as just another fad?

A new PwC survey reveals a strong need to fully embrace alternative commercial methods-not in a blind frenzy but through careful evaluation of which new sales strategies have true innovative potential.

The cholesterol-fighting market is back with a vengeance; plenty of complications in store

New EU group could ultimately end up handcuffing much-needed efforts to modernize drug authorization.

How pharma can finally put true meaning behind its juiced-up jargon and turn the bluster into reality.